Changchun High-Tech Industry Group Gets Approval to Conduct Clinical Trials for Vaccine

MT Newswires03:33 ET

Changchun High-Tech Industries (000661.SZ): The international pharmaceutical industrial park is not yet fully formally put into production.

On December 26, Geloonghui reported that Changchun High-Tech Industries (000661.SZ) stated on its investor interaction platform that the international pharmaceutical industrial park has not yet fully started production. The company's newly constructed capacity has fully taken into account the production demands for the near future, and the relevant capacity should be based on the final quantities after formal production commences.

Gelonghui Finance03:12 ET

Are Robust Financials Driving The Recent Rally In Changchun High-Tech Industry (Group) Co., Ltd.'s (SZSE:000661) Stock?

Simply Wall StDec 24 19:28 ET

Changchun High-Tech Industries (000661.SZ): The clinical trial application for the type II simple herpes virus mRNA vaccine of the controlled subsidiary has been approved.

Gelonghui reported on December 20 that Changchun High-Tech Industries (000661.SZ) announced that its holding subsidiary - Changchun Baike Biotechnology Co., Ltd. (hereinafter referred to as "Baike Biotechnology") has received the approval notice for drug clinical trials issued by the National Medical Products Administration. The clinical trial application for the Type II herpes simplex virus mRNA vaccine has been approved. Type II herpes simplex virus infection, which leads to genital herpes, is a contagious disease primarily spread through sexual contact, characterized by easy transmission, recurrence, and a lack of effective cure, becoming a serious public health issue. To prevent the occurrence of genital herpes, already several...

Gelonghui FinanceDec 20 09:13 ET

Changchun High-Tech Industry's Unit Gets Registration Certificate for Luteinizing Hormone Kit

MT NewswiresDec 18 22:33 ET

Changchun High-Tech Industries (000661.SZ): The luteinizing hormone detection kit has obtained the medical instruments registration certificate.

Gelonghui, December 18th丨Changchun High-Tech Industries (000661.SZ) announced that its subsidiary Shanghai SaiZeng Medical Technology Co., Ltd. received the "Medical Instrument Registration Certificate" (in vitro diagnostic reagents) issued by the Shanghai Municipal Drug Administration. Product name: Luteinizing Hormone Test Kit (fluorescent immunochromatography method). The acquisition of this medical instrument registration certificate further enriches the company's product line and will have a positive impact on the company's business development.

Gelonghui FinanceDec 18 05:38 ET